4 studies found for: "methodist hospital" | Open Studies | "Pancreatic Diseases" | United States, Texas | Houston
TAA-Specific CTLS for Solid Tumors (TACTASOM)
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
† Study has passed its completion date and status has not been verified in more than two years.